Early functional and structural hippocampal impairment in a bilateral common carotid artery stenosis mouse model

Abstract

Background: Subcortical ischemic vascular dementia (SIVD) is a common subtype of vascular dementia. Currently, the bilateral common carotid artery stenosis (BCAS) mouse model is the most suitable SIVD rodent model. In this study, we investigated the functional and structural impairments in the hippocampus 1 month after BCAS.

Methods: We used behavioral tests, laser speckle flowmetry, long-term potentiation, histochemical staining, molecular experiments, and voxel-based morphometry to evaluate the hippocampal impairments.

Results: Behavioral studies revealed that BCAS mice exhibited worse performance. Laser speckle flowmetry detected an obvious decrease in cerebral blood flow. The synaptic plasticity of the perforant path-dentate gyrus pathway was inhibited. Decreased fractional anisotropy and increased mean diffusivity were detected in the hippocampus via diffusion tensor imaging data. A reduction in gray matter volume, which was most prominent in the hippocampus and its surrounding areas, was detected via voxel-based morphometry analysis. Impairments in cell morphology and myelin integrity were validated using histochemical staining and molecular biology techniques. In addition, the numbers of GFAP⁺ astrocytes and Iba1⁺ microglia increased in the hippocampus.

Conclusions: Overall, our study demonstrates early functional and structural impairments in the hippocampus contributing to learning and memory deficits after 1 month of BCAS, indicating that the hippocampus is vulnerable to chronic cerebral ischemia.

Keywords

bilateral carotid artery stenosis model / hippocampus / magnetic resonance imaging / subcortical ischemic vascular dementia / voxel-based morphometry

References

[1] Rundek T, Tolea M, Ariko T, Fagerli EA, Camargo CJ. Vascular cognitive impairment (VCI). Neurotherapeutics. 2022; 19: 68-88.

[2] Chang Wong E, Chang Chui H. Vascular cognitive impairment and dementia. Continuum (Minneap, Minn). 2022; 28: 750-780.

[3] van der Flier WM, Skoog I, Schneider JA, et al. Vascular cognitive impairment. Nat Rev Dis Primers. 2018; 4: 18003.

[4] Skrobot OA, Attems J, Esiri M, et al. Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment. Brain. 2016; 139: 2957-2969.

[5] Kalaria RN. The pathology and pathophysiology of vascular dementia. Neuropharmacology. 2018; 134: 226-239.

[6] Shibata M, Ohtani R, Ihara M, Tomimoto H. White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke. 2004; 35: 2598-2603.

[7] Shibata M, Yamasaki N, Miyakawa T, et al. Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion. Stroke. 2007; 38: 2826-2832.

[8] Ihara M, Tomimoto H. Lessons from a mouse model characterizing features of vascular cognitive impairment with white matter changes. J Aging Res. 2011; 2011: 978761.

[9] Nishio K, Ihara M, Yamasaki N, et al. A mouse model characterizing features of vascular dementia with hippocampal atrophy. Stroke. 2010; 41: 1278-1284.

[10] Che P, Zhang J, Yu M, et al. Dl-3-n-butylphthalide promotes synaptic plasticity by activating the Akt/ERK signaling pathway and reduces the blood-brain barrier leakage by inhibiting the HIF-1α/MMP signaling pathway in vascular dementia model mice. CNS Neurosci Ther. 2023; 29: 1392-1404.

[11] Hao J, Chen Y, Yao E, Liu X. Soluble epoxide hydrolase inhibition alleviated cognitive impairments via NRG1/ErbB4 signaling after chronic cerebral hypoperfusion induced by bilateral carotid artery stenosis in mice. Brain Res. 2018; 1699: 89-99.

[12] Liu Q, Bhuiyan MIH, Liu R, et al. Attenuating vascular stenosis-induced astrogliosis preserves white matter integrity and cognitive function. J Neuroinflammation. 2021; 18: 187.

[13] Percie du Sert N, Hurst V, Ahluwalia A, et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. J Cereb Blood Flow Metab. 2020; 40: 1769-1777.

[14] Hattori Y, Kitamura A, Tsuji M, Nagatsuka K, Ihara M. Motor and cognitive impairment in a mouse model of ischemic carotid artery disease. Neurosci Lett. 2014; 581: 1-6.

[15] Hattori Y, Enmi JI, Iguchi S, et al. Gradual carotid artery stenosis in mice closely replicates Hypoperfusive vascular dementia in humans. J Am Heart Assoc. 2016; 5: e002757.

[16] Gao J, Li K, du L, Yin H, Tan X, Yang Z. Deletion of asparagine endopeptidase reduces anxiety- and depressive-like behaviors and improves abilities of spatial cognition in mice. Brain Res Bull. 2018; 142: 147-155.

[17] Sasaki K, Sumiyoshi A, Nonaka H, et al. Specific regions display altered grey matter volume in μ-opioid receptor knockout mice: MRI voxel-based morphometry. Br J Pharmacol. 2015; 172: 654-667.

[18] Chiang T, Messing RO, Chou WH. Mouse model of middle cerebral artery occlusion. J Vis Exp. 2011; 48: 2761.

[19] Davidson CM, Pappas BA, Stevens WD, Fortin T, Bennett SA. Chronic cerebral hypoperfusion: loss of pupillary reflex, visual impairment and retinal neurodegeneration. Brain Res. 2000; 859: 96-103.

[20] Stevens WD, Fortin T, Pappas BA. Retinal and optic nerve degeneration after chronic carotid ligation: time course and role of light exposure. Stroke. 2002; 33: 1107-1112.

[21] Takamatsu J, Hirano A, Levy D, Henkind P. Experimental bilateral carotid artery occlusion: a study of the optic nerve in the rat. Neuropathol Appl Neurobiol. 1984; 10: 423-428.

[22] Li L, He G, Shi M, et al. Edaravone dexborneol ameliorates cognitive impairment by regulating the NF-kappaB pathway through AHR and promoting microglial polarization towards the M2 phenotype in mice with bilateral carotid artery stenosis (BCAS). Eur J Pharmacol. 2023; 957: 176036.

[23] Zheng L, Jia J, Chen Y, et al. Pentoxifylline alleviates ischemic white matter injury through up-regulating Mertk-mediated myelin clearance. J Neuroinflammation. 2022; 19: 128.

[24] Zhou Z, Ma Y, Xu T, et al. Deeper cerebral hypoperfusion leads to spatial cognitive impairment in mice. Stroke Vasc Neurol. 2022; 7: 527-533.

[25] Hernandez Mercado K, Martinez Moreno A, Rodriguez Duran LF, Escobar ML, Zepeda A. Progression in time of dentate gyrus granule cell layer widening due to Excitotoxicity occurs along in vivo LTP reinstatement and contextual fear memory recovery. Neural Plast. 2022; 2022: 7432842.

[26] Zhang N, Song C, Zhao B, et al. Neovascularization and synaptic function regulation with Memantine and Rosuvastatin in a rat model of chronic cerebral Hypoperfusion. J Mol Neurosci. 2017; 63: 223-232.

[27] Xing M, Sun Q, Wang Y, Cheng Y, Zhang N. Hydroxysafflor yellow a increases BDNF and NMDARs in the hippocampus in a vascular dementia rat model. Brain Res. 2016; 1642: 419-425.

[28] Liu QY, Wang CY, Cai ZL, et al. Effects of intrahippocampal GABAB receptor antagonist treatment on the behavioral long-term potentiation and Y-maze learning performance. Neurobiol Learn Mem. 2014; 114: 26-31.

[29] Pan XC, Li ZX, Wu DZ, Li SY, Xiang HB, Song YT. Mapping changes of whole brain blood flow in rats with myocardial ischemia/reperfusion injury assessed by positron emission tomography. Current Medical Science. 2019; 39: 653-657.

[30] McColl BW, Carswell HV, McCulloch J, Horsburgh K. Extension of cerebral hypoperfusion and ischaemic pathology beyond MCA territory after intraluminal filament occlusion in C57Bl/6J mice. Brain Res. 2004; 997: 15-23.

[31] Kelly S, McCulloch J, Horsburgh K. Minimal ischaemic neuronal damage and HSP70 expression in MF1 strain mice following bilateral common carotid artery occlusion. Brain Res. 2001; 914: 185-195.

[32] Kakae M, Tobori S, Morishima M, Nagayasu K, Shirakawa H, Kaneko S. Depletion of microglia ameliorates white matter injury and cognitive impairment in a mouse chronic cerebral hypoperfusion model. Biochem Biophys Res Commun. 2019; 514: 1040-1044.

[33] Jiang P, Chen L, Sun J, et al. Chotosan ameliorates cognitive impairment and hippocampus neuronal loss in experimental vascular dementia via activating the Nrf2-mediated antioxidant pathway. J Pharmacol Sci. 2019; 139: 105-111.

[34] Xu X, Zhang B, Lu K, et al. Prevention of hippocampal neuronal damage and cognitive function deficits in vascular dementia by dextromethorphan. Mol Neurobiol. 2016; 53: 3494-3502.

[35] Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007; 8: 57-69.

[36] Rahman MS, Islam R, Bhuiyan MIH. Ion transporter cascade, reactive astrogliosis and cerebrovascular diseases. Front Pharmacol. 2024; 15: 1374408.

[37] Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer's disease. J Cell Biol. 2018; 217: 459-472.

[38] Miyamoto N, Magami S, Inaba T, et al. The effects of A1/A2 astrocytes on oligodendrocyte linage cells against white matter injury under prolonged cerebral hypoperfusion. Glia. 2020; 68: 1910-1924.

[39] Kuipers HF, Yoon J, van Horssen J, et al. Phosphorylation of αB-crystallin supports reactive astrogliosis in demyelination. Proc Natl Acad Sci USA. 2017; 114: E1745-e1754.

RIGHTS & PERMISSIONS

2025 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.